NHS Kingston
Home > 8 Malignant disease and immunosuppression > 8.3 Sex hormones and hormone antagonists in malignant disease > 8.3.4 Hormone antagonists > 8.3.4.2 Gonadorelin analogues and gonadotrophin-releasing hormone antagonists

8.3.4.2 Gonadorelin analogues and gonadotrophin-releasing hormone antagonists

Shared care guideline

Triptorelin for Central Precocious Puberty

Gonaderelin analogues

Buserelin

Injection 1mg/ml  

Buserelin

Nasal Spray 150 micrograms  

Goserelin

Implant 3.6mg

 

Goserelin Implant 10.6mg  

Leuprorelin acetate

Injection 3.75mg  

Triptorelin (Gonapeptyl Depot)

Injection 3.75mg

For the treatment of central precocious puberty only

Triptorelin (Decapeptyl SR) Injection 3mg, 11.25mg, 22.5mg  

Anti-androgens

Bicalutamide

Tablets 50mg,150mg  

Cyproterone acetate

Tablets 50mg  

Gonadotrophin-releasing hormone antagonists

Degarelix

Injection 120mg

Consultant only

For the initial treatment of patients with advanced hormone-dependent prostate cancer who require a rapid drop in testosterone such as patients with bony metastases                                                  

NICE Guidance

Site by Devopa
© Copyright 2023 NHS. All rights reserved.